breast cancer/narayanahealth.org
Nov 11, 2024, 04:24
Olaparib monotherapy in advanced TNBC patients
Akhil Santhosh, Medical Oncologist at AIIMS New Delhi, shared an article by Alfonso Cortés on X:
“Olaparib monotherapy in advanced TNBC patients with homologous recombination deficiency and without germline mutations in BRCA1/2: the NOBROLA phase 2 study –
- 6 of 114 pts eligible
- 50% ORR, CBR
- further studies needed.”
Authors: Alfonso Cortés, et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 11, 2024, 06:29
Dec 11, 2024, 05:28
Dec 11, 2024, 04:34
Dec 11, 2024, 00:01
Dec 10, 2024, 23:59
Dec 10, 2024, 23:22
Dec 10, 2024, 19:35
Dec 10, 2024, 19:22